No Detail Found!

Mast cell activation, TLR4-NF-κB/TNF-α pathway variation in rats' intestinal ischemia-reperfusion injury and Tongxinluo's therapeutic effect

Author(s)
Zhang Junxiu Institute of Traditional Chinese Medicine (TCM), Chinese People's Liberation Army General Hospital (PLAGH),Beijing,China
Feng Yu Institute of Traditional Chinese Medicine (TCM), Chinese People's Liberation Army General Hospital (PLAGH),Beijing,China
Hu Yanyan First Affiliated Hospital of PLA General Hospital,Beijing,China
Zhang Yin Institute of Traditional Chinese Medicine (TCM), Chinese People's Liberation Army General Hospital (PLAGH),Beijing,China
Liu Yi Institute of Traditional Chinese Medicine (TCM), Chinese People's Liberation Army General Hospital (PLAGH),Beijing,China
Yang Minghui Institute of Traditional Chinese Medicine (TCM), Chinese People's Liberation Army General Hospital (PLAGH),Beijing,China
Li Shaodan Institute of Traditional Chinese Medicine (TCM), Chinese People's Liberation Army General Hospital (PLAGH),Beijing,China
Abstract
This study was designed to investigate mast cell activation and related TLR4-NF-?B/TNF-α pathway variation in 3 and 7 days' rats intestinal I/R injury, and TXL's intervention effect. Rat intestine I/R injury was carried out using superior mesenteric artery occlusion model with 30 min ischemia followed 3 or 7 days' reperfusion. Rats were administered TXL ultrafine power of 0.4, 0.8 and 1.6g/kg/d respectively for 3 or 7 days after modeling. Mast cell activation was determined by immunofluorescent double staining. TLR4, ANGPTL4 and microRNA126 were determined by RT-PCR. PECAM-1, NF-κB p65, TNF-α and VE-Cadherin were determined by immunohistochemical staining. Intestine I/R induced massively mast cell activation and overexpressed TLR4, NF-κB, TNF-α, PECAM-1, miR126 in 3 and 7 days. VE-cadherin and ANGPTL4 expression was reduced. TXL treatment attenuated mast cell activation and inhibited TLR4, NF-κB, TNF-α, PECAM-1 over-expression in 3 and 7 days, protected VE-cadherin and ANGPTL4 protein. Inflammation boomed in rats' intestine I/R injury for 3 and 7 days, characterized by mast cell and related TLR4-NF-κB/TNF-α pathway activation, accompanied with endothelial barrier dysfunction and enhanced vascular permeability. TXL treatment attenuated inflammation, protected endothelial barrier function. TXL treat intestine I/R injury, according with "Treat different diseases with the same method" in TCM theory.
Publication Details
Page(s) 1599-1608
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
inflammation, intestine, I/R injury, mast cell, traditional Chinese medicine
0

Citations

0

Downloads

98

Views